Colgate-Palmolive (NYSE:CL) experienced unusually high put option trading, with 18,150 put options acquired, a 256% increase over typical volume, signaling rising bearish sentiment or hedging. This comes amid significant insider stock sales totaling nearly $17.5 million by executives like Sally Massey and Panagiotis Tsourapas. Despite these activities, the company recently beat Q4 earnings estimates and maintains a “Moderate Buy” consensus rating from analysts, though its average target price is slightly below its current trading level.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Investors Buy Large Volume of Put Options on Colgate-Palmolive (NYSE:CL)
Colgate-Palmolive (NYSE:CL) experienced unusually high put option trading, with 18,150 put options acquired, a 256% increase over typical volume, signaling rising bearish sentiment or hedging. This comes amid significant insider stock sales totaling nearly $17.5 million by executives like Sally Massey and Panagiotis Tsourapas. Despite these activities, the company recently beat Q4 earnings estimates and maintains a “Moderate Buy” consensus rating from analysts, though its average target price is slightly below its current trading level.